Generics

Filter

Current filters:

None

Popular Filters

1101 to 1125 of 1185 results

Watson 4th-quarter beats expectations, with 93% rise in net income

15-02-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) reported a whopping 62% increase to $1.5 billion…

FinancialGenericsWatson Pharmaceuticals

Rush Bill would make most patent settlement deals in USA unlawful

14-02-2012

Last week, US Representative Bobby Rush (Democrat, Illinois) introduced HR 3995, the Protecting Consumer…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Watson confirms patent challenge to Bayer’s Beyaz

13-02-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) on Friday confirmed that its subsidiary, Watson…

BayerBeyazGenericsNorth AmericaPatentsRegulationReproductiveWatson Pharmaceuticals

Fitch backs FDA planned guidelines, saying they open the door to biosimilars

12-02-2012

Fitch Ratings believes the US Federal Drug and Administration's proposed biosimilar pathway regulations,…

BiotechnologyGenericsHospiraNorth AmericaRegulation

At last, draft guidance on biosimilars pathway from US FDA

10-02-2012

Coming somewhat behind European Union action, the US Food and Drug Administration late yesterday issued…

BiotechnologyGenericsNorth AmericaRegulation

Hospira challenges Cubist patents on Cubicin

10-02-2012

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

Further protests from activists against EU and India FTA

10-02-2012

As India and the European Union meet today for a Summit in New Delhi to iron out the differences over…

Asia-PacificEuropeGenericsMarkets & MarketingPatentsPharmaceuticalPolitics

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Generics will drive Australia’s PBS saving in 2012, says GMiA

09-02-2012

Australian patients and taxpayers need to make the most of the unprecedented value of medicines coming…

Asia-PacificFinancialGenericsHealthcare

Watson settles with Janssen over Ortho Tri-Cyclen LO

08-02-2012

US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Sanofi fourth-quarter in line with forecasts; collects damages

08-02-2012

French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales…

ApotexBristol-Myers SquibbFinancialGenericsLegalPatentsPharmaceuticalPlavix

Zydus Cadila third-quarter revenues up 20%

07-02-2012

Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Shanghai Pharma aims to take control of Kony Pharma

07-02-2012

In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

New bipartisan legislation to address US drug shortages

06-02-2012

US Representatives John Carney (Democrat, Delaware) and Larry Bucshon (Republican, Indian) last week…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Dr Reddy’s beats forecasts, with 88% profits hike

06-02-2012

India drug major Dr Reddy’s Laboratories (500124: BO) saw its shares rise 2.2% to 1,670.50 rupees…

Dr Reddy's LaboratoriesFinancialGenerics

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

EC and Italian government seek to boost generic medicine use

30-01-2012

The European Commission’s formal call last week on Italy to comply with European Union rules on…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPoliticsRegulation

EC closes procedural case against Servier

29-01-2012

The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

Department of Justice seeks permanent injunction against Ranbaxy

27-01-2012

The US Department of Justice, on behalf of the Food and Drug Administration, has filed a consent decree…

Asia-PacificGenericsLegalNorth AmericaRanbaxy LaboratoriesRegulation

Kenya court set to deliver ruling on anti-counterfeit law

27-01-2012

After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

1101 to 1125 of 1185 results

Parexel

Parexel

Back to top